Sarepta Therapeutics, Inc. (SRPT) Profit Margins
Over the twelve months to 2026-06-30, Sarepta Therapeutics, Inc. (SRPT) had operating margin -7.3%, net margin -6.9%, free cash flow margin 4.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SRPTSarepta Therapeutics, Inc.Follow SRPT — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 97.6% | — | — | — | — | — | — | — | — | 98.8% | — | |
| Operating margin | -4920.3% | -111.0% | -114.1% | -185.3% | -104.5% | -65.5% | -57.5% | -21.5% | 11.5% | -31.8% | -7.3% | |
| Net margin | -4930.2% | -32.8% | -120.2% | -187.8% | -102.6% | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% | -6.9% | |
| FCF margin | -4633.1% | -157.8% | -149.4% | -135.5% | 4.7% | -68.6% | -38.2% | -46.4% | -18.0% | -14.0% | 4.1% |
USD billions · SEC XBRL
Sarepta Therapeutics, Inc. — questions
- What is Sarepta Therapeutics, Inc.'s operating margin?
- -7.3% over the twelve months to 2026-06-30.
- What is Sarepta Therapeutics, Inc.'s net profit margin?
- -6.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Sarepta Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.